Streetbeat News

Regulatory

TSLA

Tesla Inc has announced a recall of nearly 55,000 Model X vehicles due to reduced braking performance risks. The company is not aware of any crashes, injuries or deaths related to the braking error and will release a software update to fix the issue. Tesla's shares are trading slightly lower, and the company's production numbers were down due to planned factory upgrades. Reports suggest that Tesla's China-made EV sales are down more than 10% on a year-over-year basis.

Portfolio Pulse from Adam Eckert

October 17, 2023 | 1:13 pm

MBOT

Microbot Medical Inc. (NASDAQ:MBOT) announced successful initial outcomes of using its LIBERTY Robotic Surgical System in a pivotal pre-clinical study. The study was conducted by three leading interventional radiologists and achieved 100% usability and technical success with no observed complications. The company plans to submit the Investigational Device Exemption (IDE) application to the FDA, pending the final report and completion of the verification and validation process.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 1:13 pm

NVDA

NVIDIA Corporation (NVDA) has stated that it does not anticipate any significant short-term impact from the recent U.S. restrictions, according to a Bloomberg report.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 1:11 pm

SPY

The USA Redbook Year-over-Year (YoY) has reported a 4.6% increase, compared to the previous 4.0%.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:55 pm

AMD

INTC

NVDA

U.S. Treasury Secretary, Commerce Secretary, and National Security Advisor have informed China that the October 2022 update of rules on chips and chip tools will impact exports. These rules, updated annually, restrict semiconductors and chipmaking equipment to China and other countries.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:52 pm

AMD

INTC

NVDA

A new rule by a U.S. official restricts exports of chips to foreign units of companies headquartered in China, Macau, and other countries. However, most chips for consumer applications such as gaming, smartphones, or laptops can proceed without licensing.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:50 pm

NVDA

The U.S. government will restrict exports of Nvidia's A800 and H800 chips to China under updated export control rules. A limited number of chips for consumer applications will be subject to a notification requirement.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:49 pm

AMD

ASML

AVGO

FXI

A new rule from a U.S. official expands license requirements for chipmaking equipment to 21 countries other than China and for advanced chip exports to more than 40 countries. This could potentially affect several companies in the semiconductor industry.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:48 pm

ABVC

ABVC BioPharma has completed subject recruitment for an interim analysis on its ADHD Phase IIb clinical study. The study involves approximately 100 patients in the US and Taiwan. The Phase IIb study continues the Phase IIa study of ABV-1505, which achieved its primary endpoints and was accepted by the FDA in October 2020. The global ADHD treatment market is expected to reach $32.14 billion by 2030.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:41 pm

KA

Kineta, Inc. (NASDAQ:KA) has announced the first patient dosing in Part B of its Phase 1/2 VISTA-101 clinical trial. The trial will evaluate the safety and tolerability of Kineta's VISTA blocking immunotherapy, KVA12123, in combination with Merck's anti-PD-1 therapy KEYTRUDA in patients with advanced solid tumors. Initial combination therapy clinical data is expected in Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:40 pm